Naproxen sodium, can also lead to reduced tau to Ab1-42 ratio in the CSF of AD patients [34], but studies of selective cyclooxygenase-2 inhibitors failed to show any positive effect on AD patients [35]. Here, PTGS2 is linked to Alzheimer disease.